Wei Binxian 4
4 · Seneca Biopharma, Inc. · Filed Apr 7, 2020
Insider Transaction Report
Form 4
Wei Binxian
Director
Transactions
- Award
Restricted Stock Units
2020-04-03+6,000→ 6,000 total→ Common Stock (6,000 underlying)
Footnotes (3)
- [F1]Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F3]N/A